(Q36455910)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16629872%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

review article

1 reference

title

Diagnosis and management of hypertension in obesity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16629872%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

main subject

arterial hypertension

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16629872%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1

Narkiewicz K

1 reference

14 August 2017

publication date

1 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16629872%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16629872%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16629872%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16629872%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

155-162

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16629872%20AND%20SRC:MED&resulttype=core&format=json

Abdominal obesity in the United States: prevalence and attributable risk of hypertension

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2006.00226.X

Body weight, weight change, and risk for hypertension in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2006.00226.X

Overweight and hypertension : a 2-way street?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2006.00226.X

Body fat and sympathetic nerve activity in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2006.00226.X

Chronic leptin infusion increases arterial pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2006.00226.X

Usefulness of visceral obesity (waist/hip ratio) in predicting vascular endothelial function in healthy overweight adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2006.00226.X

The kidney, hypertension, and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2006.00226.X

Sympathetic activity in obese subjects with and without obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2006.00226.X

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2006.00226.X

Cardiovascular regulation in obesity-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2006.00226.X

Obesity and hypertension: two epidemics or one?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2006.00226.X

An updated coronary risk profile. A statement for health professionals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2006.00226.X

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2006.00226.X

Decrease in intra-abdominal visceral fat may reduce blood pressure in obese hypertensive women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2006.00226.X

Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2006.00226.X

Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2006.00226.X

Effect of orlistat-induced weight loss on blood pressure and heart rate in obese patients with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2006.00226.X

Choice of drug treatment for obesity-related hypertension: where is the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2006.00226.X

Adverse prognostic significance of new diabetes in treated hypertensive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2006.00226.X

Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2006.00226.X

Lisinopril versus hydrochlorothiazide in obese hypertensive patients: a multicenter placebo-controlled trial. Treatment in Obese Patients With Hypertension (TROPHY) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2006.00226.X

Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2006.00226.X

Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2006.00226.X

High prevalence of unrecognized sleep apnoea in drug-resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2006.00226.X

Chronic I(1)-imidazoline agonism : sympathetic mechanisms in hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2006.00226.X

The relation of adiposity to blood pressure and development of hypertension. The Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2006.00226.X

Human blood pressure determination by sphygmomanometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2006.00226.X

Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2006.00226.X

Sibutramine in overweight/obese hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2006.00226.X

Randomized, double-blind, placebo-controlled, multicenter study of sibutramine in obese hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2006.00226.X

Managing big issues on lean evidence: treating obesity hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2006.00226.X

10.1111/J.1467-789X.2006.00226.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16629872%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference